Cargando…

Soluble expression, purification and characterization of the full length IS2 Transposase

BACKGROUND: The two-step transposition pathway of insertion sequences of the IS3 family, and several other families, involves first the formation of a branched figure-of-eight (F-8) structure by an asymmetric single strand cleavage at one optional donor end and joining to the flanking host DNA near...

Descripción completa

Detalles Bibliográficos
Autores principales: Lewis, Leslie A, Astatke, Mekbib, Umekubo, Peter T, Alvi, Shaheen, Saby, Robert, Afrose, Jehan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219604/
https://www.ncbi.nlm.nih.gov/pubmed/22032517
http://dx.doi.org/10.1186/1759-8753-2-14
_version_ 1782216858661814272
author Lewis, Leslie A
Astatke, Mekbib
Umekubo, Peter T
Alvi, Shaheen
Saby, Robert
Afrose, Jehan
author_facet Lewis, Leslie A
Astatke, Mekbib
Umekubo, Peter T
Alvi, Shaheen
Saby, Robert
Afrose, Jehan
author_sort Lewis, Leslie A
collection PubMed
description BACKGROUND: The two-step transposition pathway of insertion sequences of the IS3 family, and several other families, involves first the formation of a branched figure-of-eight (F-8) structure by an asymmetric single strand cleavage at one optional donor end and joining to the flanking host DNA near the target end. Its conversion to a double stranded minicircle precedes the second insertional step, where both ends function as donors. In IS2, the left end which lacks donor function in Step I acquires it in Step II. The assembly of two intrinsically different protein-DNA complexes in these F-8 generating elements has been intuitively proposed, but a barrier to testing this hypothesis has been the difficulty of isolating a full length, soluble and active transposase that creates fully formed synaptic complexes in vitro with protein bound to both binding and catalytic domains of the ends. We address here a solution to expressing, purifying and structurally analyzing such a protein. RESULTS: A soluble and active IS2 transposase derivative with GFP fused to its C-terminus functions as efficiently as the native protein in in vivo transposition assays. In vitro electrophoretic mobility shift assay data show that the partially purified protein prepared under native conditions binds very efficiently to cognate DNA, utilizing both N- and C-terminal residues. As a precursor to biophysical analyses of these complexes, a fluorescence-based random mutagenesis protocol was developed that enabled a structure-function analysis of the protein with good resolution at the secondary structure level. The results extend previous structure-function work on IS3 family transposases, identifying the binding domain as a three helix H + HTH bundle and explaining the function of an atypical leucine zipper-like motif in IS2. In addition gain- and loss-of-function mutations in the catalytic active site define its role in regional and global binding and identify functional signatures that are common to the three dimensional catalytic core motif of the retroviral integrase superfamily. CONCLUSIONS: Intractably insoluble transposases, such as the IS2 transposase, prepared by solubilization protocols are often refractory to whole protein structure-function studies. The results described here have validated the use of GFP-tagging and fluorescence-based random mutagenesis in overcoming this limitation at the secondary structure level.
format Online
Article
Text
id pubmed-3219604
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32196042011-11-18 Soluble expression, purification and characterization of the full length IS2 Transposase Lewis, Leslie A Astatke, Mekbib Umekubo, Peter T Alvi, Shaheen Saby, Robert Afrose, Jehan Mob DNA Research BACKGROUND: The two-step transposition pathway of insertion sequences of the IS3 family, and several other families, involves first the formation of a branched figure-of-eight (F-8) structure by an asymmetric single strand cleavage at one optional donor end and joining to the flanking host DNA near the target end. Its conversion to a double stranded minicircle precedes the second insertional step, where both ends function as donors. In IS2, the left end which lacks donor function in Step I acquires it in Step II. The assembly of two intrinsically different protein-DNA complexes in these F-8 generating elements has been intuitively proposed, but a barrier to testing this hypothesis has been the difficulty of isolating a full length, soluble and active transposase that creates fully formed synaptic complexes in vitro with protein bound to both binding and catalytic domains of the ends. We address here a solution to expressing, purifying and structurally analyzing such a protein. RESULTS: A soluble and active IS2 transposase derivative with GFP fused to its C-terminus functions as efficiently as the native protein in in vivo transposition assays. In vitro electrophoretic mobility shift assay data show that the partially purified protein prepared under native conditions binds very efficiently to cognate DNA, utilizing both N- and C-terminal residues. As a precursor to biophysical analyses of these complexes, a fluorescence-based random mutagenesis protocol was developed that enabled a structure-function analysis of the protein with good resolution at the secondary structure level. The results extend previous structure-function work on IS3 family transposases, identifying the binding domain as a three helix H + HTH bundle and explaining the function of an atypical leucine zipper-like motif in IS2. In addition gain- and loss-of-function mutations in the catalytic active site define its role in regional and global binding and identify functional signatures that are common to the three dimensional catalytic core motif of the retroviral integrase superfamily. CONCLUSIONS: Intractably insoluble transposases, such as the IS2 transposase, prepared by solubilization protocols are often refractory to whole protein structure-function studies. The results described here have validated the use of GFP-tagging and fluorescence-based random mutagenesis in overcoming this limitation at the secondary structure level. BioMed Central 2011-10-27 /pmc/articles/PMC3219604/ /pubmed/22032517 http://dx.doi.org/10.1186/1759-8753-2-14 Text en Copyright ©2011 Lewis et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Lewis, Leslie A
Astatke, Mekbib
Umekubo, Peter T
Alvi, Shaheen
Saby, Robert
Afrose, Jehan
Soluble expression, purification and characterization of the full length IS2 Transposase
title Soluble expression, purification and characterization of the full length IS2 Transposase
title_full Soluble expression, purification and characterization of the full length IS2 Transposase
title_fullStr Soluble expression, purification and characterization of the full length IS2 Transposase
title_full_unstemmed Soluble expression, purification and characterization of the full length IS2 Transposase
title_short Soluble expression, purification and characterization of the full length IS2 Transposase
title_sort soluble expression, purification and characterization of the full length is2 transposase
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219604/
https://www.ncbi.nlm.nih.gov/pubmed/22032517
http://dx.doi.org/10.1186/1759-8753-2-14
work_keys_str_mv AT lewislesliea solubleexpressionpurificationandcharacterizationofthefulllengthis2transposase
AT astatkemekbib solubleexpressionpurificationandcharacterizationofthefulllengthis2transposase
AT umekubopetert solubleexpressionpurificationandcharacterizationofthefulllengthis2transposase
AT alvishaheen solubleexpressionpurificationandcharacterizationofthefulllengthis2transposase
AT sabyrobert solubleexpressionpurificationandcharacterizationofthefulllengthis2transposase
AT afrosejehan solubleexpressionpurificationandcharacterizationofthefulllengthis2transposase